{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:41:01Z","timestamp":1767998461180,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973996"],"award-info":[{"award-number":["81973996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oncogene-induced tumorigenesis results in the variation of epigenetic modifications, and in addition to promoting cell immortalization, cancer cells undergo more intense cellular stress than normal cells and depend on other support genes for survival. Chromosomal translocations of mixed-lineage leukemia (MLL) induce aggressive leukemias with an inferior prognosis. Unfortunately, most MLL-rearranged (MLL-r) leukemias are resistant to conventional chemotherapies. Here, we showed that hydroxyurea (HU) could kill MLL-r acute myeloid leukemia (AML) cells through the necroptosis process. HU target these cells by matrix metallopeptidase 2 (MMP2) deficiency rather than subordinate ribonucleotide reductase regulatory subunit M2 (RRM2) inhibition, where MLL directly regulates MMP2 expression and is decreased in most MLL-r AMLs. Moreover, iron chelation of HU is also indispensable for inducing cell stress, and MMP2 is the support factor to protect cells from death. Our preliminary study indicates that MMP2 might play a role in the nonsense-mediated mRNA decay pathway that prevents activation of unfolding protein response under innocuous endoplasmic reticulum stress. Hence, these results reveal a possible strategy of HU application in MLL-r AML treatment and shed new light upon HU repurposing.<\/jats:p>","DOI":"10.1038\/s41420-022-00989-4","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T11:06:19Z","timestamp":1649415979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-7511","authenticated-orcid":false,"given":"Ruiheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouhai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-3990","authenticated-orcid":false,"given":"Zhenshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-1861","authenticated-orcid":false,"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"989_CR1","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/gad.284109.116","volume":"30","author":"D Hu","year":"2016","unstructured":"Hu D, Shilatifard A. Epigenetics of hematopoiesis and hematological malignancies. Gene Dev. 2016;30:2021\u201341.","journal-title":"Gene Dev."},{"key":"989_CR2","first-page":"a009829","volume":"4","author":"J Shortt","year":"2012","unstructured":"Shortt J, Johnstone RW. Oncogenes in Cell Survival and Cell Death. Csh Perspect Biol. 2012;4:a009829\u2013a009829.","journal-title":"Csh Perspect Biol."},{"key":"989_CR3","doi-asserted-by":"crossref","unstructured":"Zhu H, Zhang L, Wu Y, Dong B, Guo W, Wang M, et al. T-ALL leukemia stem cell \u2018stemness\u2019 is epigenetically controlled by the master regulator SPI1. ELife. 2018;7:e38314.","DOI":"10.7554\/eLife.38314"},{"key":"989_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","volume":"136","author":"J Luo","year":"2009","unstructured":"Luo J, Solimini NL, Elledge SJ. Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction. Cell. 2009;136:823\u201337.","journal-title":"Cell."},{"key":"989_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.15252\/embr.201643030","volume":"17","author":"R Nagel","year":"2016","unstructured":"Nagel R, Semenova EA, Berns A. Drugging the addict: non\u2010oncogene addiction as a target for cancer therapy. EMBO Rep. 2016;17:1516\u201331.","journal-title":"EMBO Rep"},{"key":"989_CR6","doi-asserted-by":"crossref","unstructured":"Hjaltelin, JX, Izarzugaza JMG, Jensen LJ, Russo F, Westergaard D, Brunak S, et al. Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types. NPJ Syst Biol Appl. 2019;5:27.","DOI":"10.1038\/s41540-019-0104-5"},{"key":"989_CR7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4161\/cbt.8.13.8924","volume":"8","author":"H Liu","year":"2014","unstructured":"Liu H, Cheng EHY, Hsieh JJD. MLL fusions: Pathways to leukemia. Cancer Biol Ther. 2014;8:1204\u201311.","journal-title":"Cancer Biol Ther."},{"key":"989_CR8","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1038\/s41388-018-0666-5","volume":"38","author":"K Somers","year":"2019","unstructured":"Somers K, Wen VW, Middlemiss SMC, Osborne B, Forgham H, Jung M, et al. A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction. Oncogene. 2019;38:3824\u201342.","journal-title":"Oncogene."},{"key":"989_CR9","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/leu.2013.135","volume":"27","author":"C Meyer","year":"2013","unstructured":"Meyer C, Hofmann J, Burmeister T, Gr\u00f6ger D, Park TS, Emerenciano M, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013;27:2165\u201376.","journal-title":"Leukemia."},{"key":"989_CR10","doi-asserted-by":"crossref","unstructured":"Winters AC, Bernt KM. MLL-Rearranged Leukemias\u2014An Update on Science and Clinical Approaches. Front Pediatr. 2017;5:4.","DOI":"10.3389\/fped.2017.00004"},{"key":"989_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ccr.2014.03.008","volume":"25","author":"H Liu","year":"2014","unstructured":"Liu H, Westergard TD, Cashen A, Piwnica-Worms DR, Kunkle L, Vij R, et al. Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias through MLL-AF4. Cancer Cell. 2014;25:530\u201342.","journal-title":"Cancer Cell"},{"key":"989_CR12","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1172\/JCI91406","volume":"127","author":"H Okuda","year":"2017","unstructured":"Okuda H, Stanojevic B, Kanai A, Kawamura T, Takahashi S, Matsui H, et al. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia. J Clin Invest. 2017;127:1918\u201331.","journal-title":"J Clin Invest."},{"key":"989_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","volume":"122","author":"SR Daigle","year":"2013","unstructured":"Daigle SR, Olhava EJ, Therkelsen CA, Basavapathruni A, Jin L, Boriack-Sjodin PA, et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood. 2013;122:1017\u201325.","journal-title":"Blood."},{"key":"989_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4155\/fmc.13.214","volume":"6","author":"T Cierpicki","year":"2014","unstructured":"Cierpicki T, Grembecka J. Challenges and opportunities in targeting the menin\u2013MLL interaction. Future Med Chem. 2014;6:447\u201362.","journal-title":"Future Med Chem."},{"key":"989_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molcel.2013.12.001","volume":"53","author":"F Cao","year":"2014","unstructured":"Cao F, Townsend EC, Karatas H, Xu J, Li L, Lee S, et al. Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia. Mol Cell. 2014;53:247\u201361.","journal-title":"Mol Cell."},{"key":"989_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2016.12.011","volume":"168","author":"K Liang","year":"2017","unstructured":"Liang K, Volk AG, Haug JS, Marshall SA, Woodfin AR, Bartom ET, et al. Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia. Cell. 2017;168:59\u201372.e13.","journal-title":"Cell."},{"key":"989_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09350","volume":"467","author":"H Liu","year":"2010","unstructured":"Liu H, Takeda S, Kumar R, Westergard TD, Brown EJ, Pandita TK, et al. Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. Nature. 2010;467:343\u20136.","journal-title":"Nature."},{"key":"989_CR18","doi-asserted-by":"publisher","first-page":"10780","DOI":"10.1093\/nar\/gks849","volume":"40","author":"S Liu","year":"2012","unstructured":"Liu S, Opiyo SO, Manthey K, Glanzer JG, Ashley AK, Amerin C, et al. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Res. 2012;40:10780\u201394.","journal-title":"Nucleic Acids Res"},{"key":"989_CR19","doi-asserted-by":"crossref","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18:100.","DOI":"10.1186\/s12943-019-1029-8"},{"key":"989_CR20","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1073\/pnas.0530113100","volume":"100","author":"J Niquet","year":"2003","unstructured":"Niquet J, Baldwin RA, Allen SG, Fujikawa DG, Wasterlain CG. Hypoxic neuronal necrosis: Protein synthesis-independent activation of a cell death program. Proc Natl Acad Sci USA. 2003;100:2825\u201330.","journal-title":"Proc Natl Acad Sci USA."},{"key":"989_CR21","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/emboj.2009.206","volume":"28","author":"HE Bryant","year":"2009","unstructured":"Bryant HE, Petermann E, Schultz N, Jemth A, Loseva O, Issaeva N, et al. PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination. EMBO J. 2009;28:2601\u201315.","journal-title":"EMBO J"},{"key":"989_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI92742","volume":"128","author":"G Chen","year":"2018","unstructured":"Chen G, Magis AT, Xu K, Park D, Yu DS, Owonikoko TK, et al. Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy. J Clin Invest. 2018;128:500\u201316.","journal-title":"J Clin Invest."},{"key":"989_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1101\/gad.336446.120","volume":"34","author":"KA Rickman","year":"2020","unstructured":"Rickman KA, Noonan RJ, Lach FP, Sridhar S, Wang AT, Abhyankar A, et al. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links. Gene Dev. 2020;34:832\u201346.","journal-title":"Gene Dev."},{"key":"989_CR24","doi-asserted-by":"publisher","first-page":"e1335272","DOI":"10.1080\/23723556.2017.1335272","volume":"4","author":"IP Foskolou","year":"2017","unstructured":"Foskolou IP, Hammond EM. RRM2B: An oxygen-requiring protein with a role in hypoxia. Mol Cell Oncol. 2017;4:e1335272.","journal-title":"Mol Cell Oncol."},{"key":"989_CR25","doi-asserted-by":"crossref","unstructured":"Rasmussen RD, Gajjar MK, Tuckova L, Jensen KE, Maya-Mendoza A, Holst CB, et al. BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity. Nat Commun. 2016;7:13398.","DOI":"10.1038\/ncomms13398"},{"key":"989_CR26","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/onc.2014.155","volume":"34","author":"Y Aye","year":"2015","unstructured":"Aye Y, Li M, Long MJC, Weiss RS. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies. Oncogene. 2015;34:2011\u201321.","journal-title":"Oncogene."},{"key":"989_CR27","doi-asserted-by":"publisher","first-page":"18085","DOI":"10.1074\/jbc.M109.003020","volume":"284","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Jones TL, Martin SE, Caplen NJ, Pommier Y. Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response. J Biol Chem. 2009;284:18085\u201395.","journal-title":"J Biol Chem."},{"key":"989_CR28","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.ijrobp.2020.07.2322","volume":"108","author":"Q Tang","year":"2020","unstructured":"Tang Q, Wu L, Xu M, Yan D, Shao J, Yan S. Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2020;108:1368\u201379.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"989_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/1535-7163.MCT-05-0384","volume":"5","author":"J Shao","year":"2006","unstructured":"Shao J, Zhou B, Di Bilio AJ, Zhu L, Wang T, Qi C, et al. A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase. Mol Cancer Ther. 2006;5:586\u201392.","journal-title":"Mol Cancer Ther."},{"key":"989_CR30","first-page":"477","volume":"280","author":"P Navarra","year":"1997","unstructured":"Navarra P, Grohmann U, Nocentini G, Tringali G, Puccetti P, Riccardi C, et al. Hydroxyurea induces the gene expression and synthesis of proinflammatory cytokines in vivo. J Pharmacol Exp Ther. 1997;280:477\u201382.","journal-title":"J Pharmacol Exp Ther."},{"key":"989_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00280-009-0991-z","volume":"64","author":"N Saban","year":"2009","unstructured":"Saban N, Bujak M. Hydroxyurea and hydroxamic acid derivatives as antitumor drugs. Cancer Chemoth Pharm. 2009;64:213\u201321.","journal-title":"Cancer Chemoth Pharm."},{"key":"989_CR32","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1016\/j.bmcl.2006.05.068","volume":"16","author":"C Temperini","year":"2006","unstructured":"Temperini C, Innocenti A, Scozzafava A, Supuran CT. N-Hydroxyurea\u2014A versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg Med Chem Lett. 2006;16:4316\u201320.","journal-title":"Bioorg Med Chem Lett."},{"key":"989_CR33","doi-asserted-by":"publisher","first-page":"112679","DOI":"10.1016\/j.ejmech.2020.112679","volume":"205","author":"W Liu","year":"2020","unstructured":"Liu W, Liang Y, Si X. Hydroxamic acid hybrids as the potential anticancer agents: An Overview. Eur. J Med Chem. 2020;205:112679.","journal-title":"J Med Chem."},{"key":"989_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbamcr.2009.07.004","volume":"1803","author":"M Fanjul-Fern\u00e1ndez","year":"2010","unstructured":"Fanjul-Fern\u00e1ndez M, et al. Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochim Biophy. Acta Mol Cell Res. 2010;1803:3\u201319.","journal-title":"Biochim Biophy. Acta Mol Cell Res."},{"key":"989_CR35","doi-asserted-by":"publisher","first-page":"e2940","DOI":"10.1038\/cddis.2017.285","volume":"8","author":"C Zhang","year":"2017","unstructured":"Zhang C, Song C, Liu T, Tang R, Chen M, Gao F, et al. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway. Cell Death Dis. 2017;8:e2940\u2013e2940.","journal-title":"Cell Death Dis"},{"key":"989_CR36","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/onc.2009.6","volume":"28","author":"I Robert","year":"2009","unstructured":"Robert I, Aussems M, Keutgens A, Zhang X, Hennuy B, Viatour P, et al. Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-\u03baB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene. 2009;28:1626\u201338.","journal-title":"Oncogene."},{"key":"989_CR37","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.bbamcr.2017.05.013","volume":"1864","author":"PG Jobin","year":"2017","unstructured":"Jobin PG, Butler GS, Overall CM. New intracellular activities of matrix metalloproteinases shine in the moonlight. Biochim Biophys Acta Mol Cell Res. 2017;1864:2043\u201355.","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"key":"989_CR38","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nm.3993","volume":"21","author":"MT Esposito","year":"2015","unstructured":"Esposito MT, Zhao L, Fung TK, Rane JK, Wilson A, Martin N, et al. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nat Med. 2015;21:1481\u201390.","journal-title":"Nat Med."},{"key":"989_CR39","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1111\/cas.14892","volume":"112","author":"M Ge","year":"2021","unstructured":"Ge M, Xu Q, Kang T, Li D, Wang R, Chen Z, et al. Deubiquitinating enzyme inhibitor alleviates cyclin A1\u2010mediated proteasome inhibitor tolerance in mixed\u2010lineage leukemia. Cancer Sci. 2021;112:2287\u201398.","journal-title":"Cancer Sci"},{"key":"989_CR40","doi-asserted-by":"crossref","unstructured":"Chong SY, et al. H3K4 methylation at active genes mitigates transcription-replication conflicts during replication stress. Nat. Commun. 2020;11:809.","DOI":"10.1038\/s41467-020-14595-4"},{"key":"989_CR41","first-page":"E1016","volume":"110","author":"SY Chong","year":"2013","unstructured":"Chong SY, Cutler S, Lin J, Tsai C, Tsai H, Biggins S, et al. H3K4 methyltransferase Set1 is involved in maintenance of ergosterol homeostasis and resistance to Brefeldin A. Proc Natl Acad Sci USA. 2013;110:E1016\u2013E1025.","journal-title":"Proc Natl Acad Sci USA."},{"key":"989_CR42","doi-asserted-by":"crossref","unstructured":"Chartier M, Morency L, Zylber MI, Najmanovich RJ. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects. BMC Pharmacol Toxicol. 2017;18:18.","DOI":"10.1186\/s40360-017-0128-7"},{"key":"989_CR43","doi-asserted-by":"publisher","first-page":"e1005135","DOI":"10.1371\/journal.pcbi.1005135","volume":"12","author":"H Lim","year":"2016","unstructured":"Lim H, Poleksic A, Yao Y, Tong H, He D, Zhuang L, et al. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing. Plos Comput Biol. 2016;12:e1005135.","journal-title":"Plos Comput Biol."},{"key":"989_CR44","doi-asserted-by":"crossref","unstructured":"Ramsay RR, Popovic Nikolic, MR, Nikolic K, Uliassi E, Bolognesi ML. A perspective on multi\u2010target drug discovery and design for complex diseases. Clin Transl Med. 2018;7:3.","DOI":"10.1186\/s40169-017-0181-2"},{"key":"989_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/genes7110099","volume":"7","author":"A Singh","year":"2016","unstructured":"Singh A, Xu Y. The Cell Killing Mechanisms of Hydroxyurea. Genes. 2016;7:99.","journal-title":"Genes."},{"key":"989_CR46","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.molcel.2010.01.021","volume":"37","author":"E Petermann","year":"2010","unstructured":"Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair. Mol Cell. 2010;37:492\u2013502.","journal-title":"Mol Cell."},{"key":"989_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1363-4","volume":"571","author":"M Daza-Martin","year":"2019","unstructured":"Daza-Martin M, Starowicz K, Jamshad M, Tye S, Ronson GE, MacKay HL, et al. Isomerization of BRCA1\u2013BARD1 promotes replication fork protection. Nature. 2019;571:521\u20137.","journal-title":"Nature."},{"key":"989_CR48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ccell.2015.09.015","volume":"28","author":"SX Pfister","year":"2015","unstructured":"Pfister SX, Markkanen E, Jiang Y, Sarkar S, Woodcock M, Orlando G, et al. Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation. Cancer Cell. 2015;28:557\u201368.","journal-title":"Cancer Cell"},{"key":"989_CR49","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.celrep.2016.10.024","volume":"17","author":"LP Liew","year":"2016","unstructured":"Liew LP, Lim Y, Cohen M, Kong Z, Marjavaara L, Chabes A, et al. Hydroxyurea-Mediated Cytotoxicity Without Inhibition of Ribonucleotide Reductase. Cell Rep. 2016;17:1657\u201370.","journal-title":"Cell Rep."},{"key":"989_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijpddr.2021.01.003","volume":"15","author":"P Das","year":"2021","unstructured":"Das P, Saha S, BoseDasgupta S. The ultimate fate determinants of drug induced cell-death mechanisms in Trypanosomatids. Int J Parasitol.-Drug. 2021;15:81\u201391.","journal-title":"Int J Parasitol.-Drug."},{"key":"989_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/toxsci\/kfr098","volume":"122","author":"SM Sancho-Mart\u00ednez","year":"2011","unstructured":"Sancho-Mart\u00ednez SM, Piedrafita FJ, Cannata-And\u00eda JB, L\u00f3pez-Novoa JM, L\u00f3pez-Hern\u00e1ndez FJ. Necrotic Concentrations of Cisplatin Activate the Apoptotic Machinery but Inhibit Effector Caspases and Interfere with the Execution of Apoptosis. Toxicol Sci. 2011;122:73\u201385.","journal-title":"Toxicol Sci."},{"key":"989_CR52","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1096\/fj.02-1202fje","volume":"18","author":"JA Kwan","year":"2004","unstructured":"Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, et al. Matrix metalloproteinase\u20102 (MMP\u20102) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP\u2010ribose) polymerase (PARP) in vitro. FASEB J. 2004;18:690\u20132.","journal-title":"FASEB J."},{"key":"989_CR53","doi-asserted-by":"crossref","unstructured":"Xie Y, Mustafa A, Yerzhan A, Merzhakupova D, Yerlan P, N Orakov A, et al. Nuclear matrix metalloproteinases: functions resemble the evolution from the intracellular to the extracellular compartment. Cell Death Discov. 2017;3:17036.","DOI":"10.1038\/cddiscovery.2017.36"},{"key":"989_CR54","doi-asserted-by":"crossref","unstructured":"Bassiouni W, Ali MAM, Schulz R. Multifunctional intracellular matrix metalloproteinases: implications in disease. FEBS J. 2021.","DOI":"10.1111\/febs.15701"},{"key":"989_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.15252\/embr.201439696","volume":"16","author":"R Karam","year":"2015","unstructured":"Karam R, Lou CH, Kroeger H, Huang L, Lin JH, Wilkinson MF. The unfolded protein response is shaped by the NMD pathway. EMBO Rep. 2015;16:599\u2013609.","journal-title":"EMBO Rep."},{"key":"989_CR56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2174\/092986708783497300","volume":"15","author":"XC Cheng","year":"2008","unstructured":"Cheng XC, Wang Q, Fang H, Xu WF. Role of sulfonamide group in matrix metalloproteinase inhibitors. Curr Med Chem. 2008;15:368\u201373.","journal-title":"Curr Med Chem."}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00989-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00989-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00989-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:25:16Z","timestamp":1669303516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00989-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-00989-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}